Search

everythinglearnresearchcommunity

for

Search:↓

Anti-CD19 therapy may help treat SLE and NMOSD.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Transplant patients often get skin problems, with treatments varying by condition.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.